Betahistine Therapy

Betahistine Therapy is a pharmacological treatment modality that specifically involves the administration of betahistine dihydrochloride to alleviate vestibular symptoms in Ménière’s disease by purportedly enhancing inner ear microcirculation and reducing endolymphatic hydrops.

140

Publications

4.8K

Citations

490

Authors

230

Institutions

Publications per year

2017–2026

26

Authors

490

  1. MS
    Michael Strupp

    Ludwig-Maximilians-Universität München, Germany

    9 publications · 654 citations

    9

    h-index

  2. JL
    Jiamei Lian

    University of Wollongong, Australia

    6 publications · 298 citations

    6

    h-index

  3. CD
    Chao Deng

    University of Wollongong, Australia

    6 publications · 298 citations

    6

    h-index

  4. XH
    Xu‐Feng Huang

    University of Wollongong, Australia

    6 publications · 265 citations

    6

    h-index

  5. BT
    Brahim Tighilet

    Centre National de la Recherche Scientifique, France

    5 publications · 309 citations

    5

    h-index

1–5 of 490

Venues

  1. Acta Oto-Laryngologica

    16 publications · 506 citations

    14

    h-index

  2. PubMed

    Repository · 19 publications · 437 citations

    12

    h-index

  3. The Journal of Laryngology & Otology

    7 publications · 321 citations

    7

    h-index

  4. European Archives of Oto-Rhino-Laryngology

    6 publications · 341 citations

    6

    h-index

  5. Brazilian Journal of Otorhinolaryngology

    4 publications · 80 citations

    4

    h-index

1–5